FuturHealth Strengthens Executive Team to Accelerate Growth and Engagement on Its Weight-Loss Platform

Keith Koch Joins as EVP of Growth Product & Experience Design, Bringing Decades of Expertise in Healthcare and E-commerce

SAN DIEGO, CA – April 15, 2025 – FuturHealth, a leader in personalized weight-loss solutions, today announced the appointment of Keith Koch as Executive Vice President of Growth Product & Experience Design. Koch, a veteran in digital healthcare and e-commerce, will spearhead product innovation and engagement strategies to enhance the company’s platform and drive sustained patient success.

“Keith is a visionary in product development and digital transformation, and we’re thrilled to have him on board,” said Luke Mahoney, co-founder and CEO of FuturHealth. “His expertise in scaling platforms and driving patient engagement will be invaluable as we continue to expand, deepen partnerships, and deliver even better outcomes for our users.”

Koch brings over two decades of leadership across Walmart Health, Optum, and UnitedHealthcare, where he led groundbreaking digital health initiatives. As Head of Product for Walmart Health, he built the company’s healthcare digital capabilities from the ground up, fueling a 583% increase in revenue, a 5x rise in patient visits, and an NPS jump from 67 to 86. At Optum, he drove major digital transformation efforts across OptumRx, OptumBank, and UnitedHealthcare, launching virtual assistants and secure messaging platforms that improved customer self-service and retention.

“I’m excited to join FuturHealth at such a pivotal time in the weight-loss industry,” said Koch. “GLP-1 treatments are transforming the space, but real, lasting results come from a holistic approach. I look forward to helping FuturHealth scale its platform and further integrate personalized support, nutrition, and expert care to improve long-term health outcomes.”

FuturHealth’s all-in-one platform combines personalized treatment, expert guidance, and tailored nutrition plans to support users at every stage of their weight-loss journey. Patients start with an in-depth assessment to match their needs with the right plan, then receive ongoing virtual consultations with licensed medical providers. The company’s doctor- and dietitian-designed meal plans empower users with sustainable habits during and after GLP-1 treatment, ensuring long-term success.

Koch’s appointment follows FuturHealth’s recent strategic partnerships with Affirm and Valisure, as well as compelling efficacy data from a large-scale study with InCSD. The study confirmed that combining FuturHealth’s program with GLP-1 medications like Semaglutide and Tirzepatide significantly enhances weight-loss results compared to medication alone.

For more information about FuturHealth’s innovative approach, visit www.fh.co

About FuturHealth:

FuturHealth is your partner in weight loss, providing personalized guidance designed to work with your everyday life. Together with a team of doctors, dieticians, and weight-loss experts, we combine scientifically-proven medications with clinically-crafted, expertly-curated meals for quick, easy, effective, and affordable wins. Founded with a mission to create a holistic and personalized alternative to traditional, one-size-fits-all weight-loss solutions, we meet each person where they are on their unique journey, empowering them to confidently take control of their well-being at every step of the way. With a network of 350+ providers across 48 states, FuturHealth has transformed the lives of over 1.5 million patients and counting. In under a year, it has achieved an extraordinary 980% growth in active patients and facilitated over 6 billion online interactions.

Contact:
Autumn Communications
[email protected]